NCT01151943

Brief Summary

Women undergoing elective cesarean delivery, performed under a standard spinal anesthesia, will be randomized to undergo either TAP block or incisional infiltration with local anesthetic, in addition to standard postoperative analgesia comprising regular acetaminophen, nefopam and ketoprofen. Short acting oral morphine will be given as a rescue treatment in case of severe pain.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
77

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Oct 2010

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2010

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 29, 2010

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2010

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
Last Updated

November 3, 2016

Status Verified

November 1, 2016

Enrollment Period

1.8 years

First QC Date

June 24, 2010

Last Update Submit

November 2, 2016

Conditions

Keywords

cesarean sectioncontinuous wound infiltrationtransversus abdominis plane block

Outcome Measures

Primary Outcomes (1)

  • severity of postoperative pain

    48 postoperative hours

Secondary Outcomes (6)

  • delay before the first rescue dose of morphine

    48 postoperative hours

  • morphine requirement

    48 postoperative hours

  • complication of each loco-regional technique

    end of hospitalisation

  • patient's satisfaction

    end of hospitalisation

  • length of hospital stay

    end of hospitalisation

  • +1 more secondary outcomes

Study Arms (2)

Transversus Abdominis Plane (TAP) Block

EXPERIMENTAL

Patients will receive a bilateral transversus abdominis plane block

Other: Transversus Abdominis Plane (TAP) Block

Incisional Infiltration of Local Anesthetic

ACTIVE COMPARATOR

Patients will receive an incisional infiltration with local anesthetic (continuous administration of levobupivacaïne during 48 hours)

Other: Incisional Infiltration of Local Anesthetic

Interventions

Bilateral injection of levobupivacaine (20 mL, 3.75 mg/mL)

Transversus Abdominis Plane (TAP) Block

continuous administration of levobupivacaine (1,25 mg/mL,5 mL/h) during 48 hours.

Incisional Infiltration of Local Anesthetic

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • scheduled cesarean section performed under spinal anesthesia
  • ASA I or II
  • height above 1,55 m
  • singleton pregnancy

You may not qualify if:

  • contre indication to a drug used in the study (levobupivacaine, ketoprofen, nefopam)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Foch

Suresnes, 92150, France

Location

Related Publications (1)

  • Chandon M, Bonnet A, Burg Y, Barnichon C, DesMesnards-Smaja V, Sitbon B, Foiret C, Dreyfus JF, Rahmani J, Laloe PA, Fischler M, Le Guen M. Ultrasound-guided Transversus Abdominis plane block versus continuous wound infusion for post-caesarean analgesia: a randomized trial. PLoS One. 2014 Aug 5;9(8):e103971. doi: 10.1371/journal.pone.0103971. eCollection 2014.

MeSH Terms

Interventions

Dental Occlusion

Intervention Hierarchy (Ancestors)

DentistryDental Physiological PhenomenaDigestive System and Oral Physiological Phenomena

Study Officials

  • Marc Fischler, MD

    Hôpital Foch

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2010

First Posted

June 29, 2010

Study Start

October 1, 2010

Primary Completion

July 1, 2012

Study Completion

July 1, 2012

Last Updated

November 3, 2016

Record last verified: 2016-11

Locations